Glycerol adjuvant therapy in adults with bacterial meningitis in a high HIV seroprevalence setting in Malawi: a double-blind, randomised controlled trial
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Summary Background Southern Africa has a high incidence of bacterial meningitis in adults, often associated with HIV co-infection. Even with appropriate antibiotic therapy, mortality exceeds 50% and is not improved with corticosteroids. Glycerol adjuvant therapy reduced mortality and long-term morbidity (deafness) in bacterial meningitis in children and is being promoted. If similarly effective in adults, glycerol would provide a cheap, available adjuvant therapy in Africa. Methods Following a dose-finding study, we conducted a randomised double-blind placebo-controlled trial of oral glycerol in adults with bacterial meningitis. Patients with clinical and CSF findings suggestive of bacterial meningitis were randomised either to glycerol or an equivalent volume of sugar solution. The primary outcome was mortality at 40 days with secondary outcomes including disability and mortality restricted to pneumococcal disease. Findings 75ml glycerol QDS was best tolerated and was used for the main study. 265 patients were randomised to receive glycerol or placebo. The trial was stopped early on the advice of the Data and Safety Monitoring Board (DSMB) following a planned interim analysis. Mortality by day 40 was 61/125 (49%) in the placebo and 86/136 (69%) in the glycerol arms, Adjusted Odds Ratio 2·4 (95% CI 1·3-4·2 p0·003). There was no benefit from glycerol for death and disability by day 40 by intention to treat or in predefined subgroups. Two serious adverse events occurred possibly due to study drug. Interpretation Oral glycerol therapy did not improve mortality in adults with bacterial meningitis and cannot be recommended as a suitable adjuvant therapy in resource-poor settings with a high HIV prevalence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Capes, S. E., Hunt, D., Malmberg, K., & Gerstein, H. C. (2000) · The Lancet · doi:10.1016/s0140-6736(99)08415-9 · Cited by 2,187
Capes, S. E., Hunt, D., Malmberg, K., Pathak, P., & Gerstein, H. C. (2001) · Stroke · doi:10.1161/hs1001.096194 · Cited by 1,824
Research works printed but not linked: 34
- Gordon, 2000, Bacterial meningitis in Malawian adults: pneumococcal disease is common, severe, and seasonal, Clin Infect Dis, 31, 53, 10.1086/313910 · DOI · Paper page
- Scarborough, 2007, Corticosteroids for bacterial meningitis in adults in sub-saharan Africa, N Engl J Med, 357, 2441, 10.1056/NEJMoa065711 · DOI · Paper page
- Gordon, 2002, Pneumococcal disease in HIV-infected Malawian adults: acute mortality and long-term survival, AIDS, 16, 1409, 10.1097/00002030-200207050-00013 · DOI
- de Gans, 2002, Dexamethasone in adults with bacterial meningitis, N Engl J Med, 347, 1549, 10.1056/NEJMoa021334 · DOI · Paper page
- Molyneux, 2002, Dexamethasone treatment in childhood bacterial meningitis in Malawi, Lancet, 360, 211, 10.1016/S0140-6736(02)09458-8 · DOI · Paper page
- van de Beek, 2010, Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data, Lancet Neurol, 9, 254, 10.1016/S1474-4422(10)70023-5 · DOI · Paper page
- Kilpi, 1995, Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis, Pediatr Infect Dis J, 14, 270, 10.1097/00006454-199504000-00005 · DOI · Paper page
- Peltola, 2007, Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial, Clin Infect Dis, 45, 1277, 10.1086/522534 · DOI · Paper page
- Sáez-Llorens, 2007, Glycerol and bacterial meningitis, Clin Infect Dis, 45, 1287, 10.1086/522536 · DOI
- Menger, 1971, Treatment with glycerol of cerebral oedema due to acute cerebral infarction, Lancet, 2, 993
- Gilsanz, 1975, Controlled trial of glycerol versus dexamethasone in the treatment of cerebral oedema in acute cerebral infarction, Lancet, 1, 1049, 10.1016/S0140-6736(75)91825-5 · DOI
- Bayer, 1987, Double-blind randomised trial of intravenous glycerol in acute stroke, Lancet, 1, 405, 10.1016/S0140-6736(87)90117-6 · DOI
- Yu, 1993, Treatment of acute cortical infarct with intravenous glycerol: a double-blind, placebo-controlled randomized trial, Stroke, 24, 1119, 10.1161/01.STR.24.8.1119 · DOI
- Cantore, 1964, Oral glycerol for the reduction of intracranial pressure, J Neurosurg, 21, 278, 10.3171/jns.1964.21.4.0278 · doi:10.3171/jns.1964.21.4.0278
- Wald, 1982, Oral glycerol for the treatment of traumatic intracranial hypertension, J Neurosurg, 56, 323, 10.3171/jns.1982.56.3.0323 · DOI
- Biestro, 1997, Osmotherapy for increased intracranial pressure: comparison between mannitol and glycerol, Acta Neurochir (Wien), 139, 725, 10.1007/BF01420045 · DOI
- Casey, 1963, Oral glycerol in glaucoma, BMJ, 2, 851, 10.1136/bmj.2.5361.851 · DOI
- Awasthi, 1965, Role of oral glycerol in glaucoma, Br J Ophthalmol, 49, 660, 10.1136/bjo.49.12.660 · DOI
- Righetti, 2004, Glycerol for acute stroke, Cochrane Database Syst Rev, 2
- Frank, 1981, Glycerol: a review of its pharmacology, pharmacokinetics, adverse reactions, and clinical use, Pharmacotherapy, 1, 147, 10.1002/j.1875-9114.1981.tb03562.x · DOI · Paper page
- Bingel, 2006, Acute encephalopathy due to glycerol over-consumption, J Neurol, 253, 125, 10.1007/s00415-005-0924-7 · doi:10.1007/s00415-005-0924-7
- Thornit, 2009, The effects of peroral glycerol on plasma osmolarity in diabetic patients and healthy individuals, Basic Clin Pharmacol Toxicol, 105, 289, 10.1111/j.1742-7843.2009.00462.x · doi:10.1111/j.1742-7843.2009.00462.x
- Singh, 2001, Reversible neurologic manifestation after glycerol: a short report, Neurology India, 49, 320
- Lewis, 2003, Prevalence and indicators of HIV and IADS among adults admitted to medical and surgical wards in Blantyre, Malawi, Trans R Soc Trop Med Hyg, 97, 91, 10.1016/S0035-9203(03)90035-6 · doi:10.1016/s0035-9203(03)90035-6
- Sankar, 2007, Role of dexamethasone and oral glycerol in reducing hearing and neurological sequelae in children with bacterial meningitis, Indian Pediatrics, 44, 649
- Rottenberg, 1977, The effect of oral glycerol on intraventricular pressure in man, Neurology, 27, 600, 10.1212/WNL.27.7.600 · doi:10.1212/wnl.27.7.600
- Blaser, 2010, Adjuvant glycerol is not beneficial in experimental pneumococcal meningitis, BMC Infect Dis, 10, 84, 10.1186/1471-2334-10-84 · DOI
- Coursin, 2004, Perioperative diabetic and hyperglycemic management issues, Critical Care Medicine, 32, S116, 10.1097/01.CCM.0000115623.52021.C0 · DOI
- Baker, 2006, Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease, Thorax, 61, 284, 10.1136/thx.2005.051029 · DOI · Paper page
- Donnelly, 1999, Glycerol-induced seizure: involvement of IL-1beta and glutamate, Neuroreport, 10, 1821, 10.1097/00001756-199906230-00004 · DOI
- Garcia-Sola, 1991, The immediate and longterm effects of mannitol and glycerol, Acta Neurochir, 109, 114, 10.1007/BF01403005 · doi:10.1007/bf01403005
- Nau, 1992, Temporary reversal of serum to cerebrospinal fluid glycerol concentration gradient after intravenous infusion of glycerol, Eur J Clin Pharmacol, 42, 181, 10.1007/BF00278481 · DOI
- Pitlick, 1982, Effects of glycerol and hyperosmolality on intracranial pressure, Clin Pharmacol Ther, 31, 466, 10.1038/clpt.1982.61 · doi:10.1038/clpt.1982.61
- Guisado, 1975, Rebound phenomenon complicating cerebral dehydration with glycerol, J Neurosurg, 42, 226, 10.3171/jns.1975.42.2.0226 · doi:10.3171/jns.1975.42.2.0226
Cited by
Pathogenesis and Pathophysiology of Pneumococcal Meningitis
Mook-Kanamori, B. B., Geldhoff, M., van der Poll, T., & van de Beek, D. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00008-11 · Cited by 492
Guidelines for the Acute Treatment of Cerebral Edema in Neurocritical Care Patients
Cook, A. M., Morgan Jones, G., Hawryluk, G. W. J., Mailloux, P., McLaughlin, D., Papangelou, A., Samuel, S., Tokumaru, S., Venkatasubramanian, C., Zacko, C., et al. (2020) · Neurocritical Care · doi:10.1007/s12028-020-00959-7 · Cited by 447
Advances in treatment of bacterial meningitis
van de Beek, D., Brouwer, M. C., Thwaites, G. E., & Tunkel, A. R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61186-6 · Cited by 336
Community-acquired bacterial meningitis.
van de Beek, D., Brouwer, M. C., Koedel, U., & Wall, E. C. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00883-7 · Cited by 292
Acute bacterial meningitis in adults
McGill, F., Heyderman, R. S., Panagiotou, S., Tunkel, A. R., & Solomon, T. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30654-7 · Cited by 274
Metadata
- Authors
- Ajdukiewicz, K. M., Cartwright, K. E., Scarborough, M., Mwambene, J. B., Goodson, P., Molyneux, M. E., Zijlstra, E. E., French, N., Whitty, C. J., & Lalloo, D. G.
- Venue
- The Lancet Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2011-04
- Volume
- 11
- Issue
- 4
- Pages
- 293-300
- ISSN
- 1473-3099 (ISSN-L)
- OpenAlex
- W2170414257
- Cited by
- 90
- References
- 3
- FWCI
- 8.11
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glycerol adjuvant therapy in adults with bacterial meningitis in a high HIV seroprevalence setting in Malawi: a double-blind, randomised controlled trial. https://app.cochat.ai/papers/10.1016/s1473-3099(10)70317-0
- The paper
- Ajdukiewicz, K. M., Cartwright, K. E., Scarborough, M., Mwambene, J. B., Goodson, P., Molyneux, M. E., Zijlstra, E. E., French, N., Whitty, C. J., & Lalloo, D. G. (2011). Glycerol adjuvant therapy in adults with bacterial meningitis in a high HIV seroprevalence setting in Malawi: a double-blind, randomised controlled trial. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(10)70317-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.